Efficacy and safety of autologous platelet-rich plasma in anal fistula: a systematic review and meta-analysis.

Annals of Saudi medicine Pub Date : 2024-07-01 Epub Date: 2024-08-01 DOI:10.5144/0256-4947.2024.264

Yuanhui Xu, Lin Ma, Keliang Jia, Xiaoling Wu, Chang Ge

{"title":"Efficacy and safety of autologous platelet-rich plasma in anal fistula: a systematic review and meta-analysis.","authors":"Yuanhui Xu, Lin Ma, Keliang Jia, Xiaoling Wu, Chang Ge","doi":"10.5144/0256-4947.2024.264","DOIUrl":null,"url":null,"abstract":"Introduction: This study aimed to determine the efficacy and safety of autologous PRP in anal fistula.Methods: The search was done in electronic databases such as; PubMed, Scopus, Google Scholar, Embase, and Cochrane Library. The outcomes investigated in this study were the rate of improvement, the rate of recurrence, and the rate of fecal incontinence.Results: Cure, incontinence, and recurrence rates were 68% (95% CI, .60-.76), 27% (95% CI, .12-.46), and 18% (95% CI, .12-.26), respectively. The pooled improvement ratio in patients treated with PRP compared to control group was 1.35 times, which was statistically significant (pooled OR=1.35, 95% CI, 1.14-1.60, P<001). The pooled recurrence ratio in patients treated with PRP compared to control group was 1.17, which was not statistically significant (pooled OR=1.17, 95% CI, 0.44-3.11).Discussion: Platelet-rich plasma is an effective method of healing people with anal fistula.","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316947/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Saudi medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5144/0256-4947.2024.264","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/1 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: This study aimed to determine the efficacy and safety of autologous PRP in anal fistula.

Methods: The search was done in electronic databases such as; PubMed, Scopus, Google Scholar, Embase, and Cochrane Library. The outcomes investigated in this study were the rate of improvement, the rate of recurrence, and the rate of fecal incontinence.

Results: Cure, incontinence, and recurrence rates were 68% (95% CI, .60-.76), 27% (95% CI, .12-.46), and 18% (95% CI, .12-.26), respectively. The pooled improvement ratio in patients treated with PRP compared to control group was 1.35 times, which was statistically significant (pooled OR=1.35, 95% CI, 1.14-1.60, P<001). The pooled recurrence ratio in patients treated with PRP compared to control group was 1.17, which was not statistically significant (pooled OR=1.17, 95% CI, 0.44-3.11).

Discussion: Platelet-rich plasma is an effective method of healing people with anal fistula.

查看原文本刊更多论文

自体富血小板血浆治疗肛瘘的有效性和安全性：系统回顾和荟萃分析。

简介：本研究旨在确定自体PRP治疗肛瘘的有效性和安全性：本研究旨在确定自体 PRP 治疗肛瘘的有效性和安全性：在 PubMed、Scopus、Google Scholar、Embase 和 Cochrane Library 等电子数据库中进行了搜索。本研究调查的结果为痊愈率、复发率和大便失禁率：治愈率、大便失禁率和复发率分别为 68% (95% CI, .60-.76)、27% (95% CI, .12-.46) 和 18% (95% CI, .12-.26)。与对照组相比，使用富血小板血浆治疗的患者的总改善率为 1.35 倍，具有统计学意义（总 OR=1.35，95% CI，1.14-1.60，PDiscussion：富血小板血浆是治愈肛瘘患者的有效方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Saudi medicine

自引率

0.00%

发文量